XML 71 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information
3 Months Ended
Mar. 29, 2014
Segment Reporting [Abstract]  
Business Segment Information
BUSINESS SEGMENT INFORMATION
We report two business segments, Research Models and Services (RMS) and Preclinical Services (PCS). Our RMS segment includes sales of Research Models, Genetically Engineered Models and Services (GEMS), Insourcing Solutions (IS), Research Animal Diagnostic Services (RADS), Discovery Services (DS), Endotoxin and Microbial Detection (EMD) products and services, and Avian Vaccine products and services. Our PCS segment includes services required to take a drug through the development process, which includes DS, safety assessment and Biologics Testing Services.
The following table presents sales and other financial information by business segment.
 
Three Months Ended
 
March 29, 2014
 
March 30, 2013
Research Models and Services
 
 
 
Revenue
$
185,615

 
$
182,489

Gross margin
80,979

 
80,435

Operating income
53,540

 
55,303

Depreciation and amortization
10,690

 
9,873

Capital expenditures
6,868

 
4,010

Preclinical Services
 
 
 
Revenue
$
113,753

 
$
108,749

Gross margin
27,834

 
23,776

Operating income
12,033

 
8,060

Depreciation and amortization
9,361

 
10,137

Capital expenditures
4,322

 
2,418


A reconciliation of segment operating income to consolidated operating income is as follows:
 
Three Months Ended
 
March 29, 2014
 
March 30, 2013
Total segment operating income
$
65,573

 
$
63,363

Unallocated corporate overhead
(25,867
)
 
(20,600
)
Consolidated operating income
$
39,706

 
$
42,763


Revenue for each significant product or service area are as follows:
 
Three Months Ended
 
March 29, 2014
 
March 30, 2013
Research models
$
99,355

 
$
103,123

Research model services
53,795

 
52,154

EMD
32,465

 
27,212

Total research models and services
185,615

 
182,489

Total preclinical services
113,753

 
108,749

Total revenue
$
299,368

 
$
291,238



A summary of unallocated corporate overhead consists of the following:
 
Three Months Ended
 
March 29, 2014
 
March 30, 2013
Stock-based compensation expense
$
3,702

 
$
3,197

U.S. retirement plans
644

 
1,300

Audit, tax and related expense
1,906

 
1,235

Salary and bonus
6,139

 
4,755

Global IT
2,869

 
2,586

Employee health, long-term disability and fringe benefit expense
2,319

 
2,228

Consulting and professional services
1,182

 
688

Depreciation expense
1,600

 
1,570

Other general unallocated corporate expenses
5,506

 
3,041

Total unallocated corporate overhead costs
$
25,867

 
$
20,600


Other general unallocated corporate expenses consist of various departmental costs including those associated with senior executives, corporate accounting, legal, tax, human resources and treasury.